1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Athlete’s foot- Epidemiology Forecast to 2030

Athlete’s foot- Epidemiology Forecast to 2030

  • May 2020
  • 100 pages
  • ID: 5897609
  • Format: PDF
  • Delve Insight


Table of Contents

‘Athlete’s foot - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Athlete’s foot epidemiology in the United States.

Athlete’s foot Understanding
Athlete’s foot, also known as Tinea pedis, is a cutaneous fungal infection caused by a dermatophyte infection. It is characterized by itching, flaking, and fissuring of the skin. It may manifest in three ways: the skin between the toes may appear macerated (white) and soggy; the soles of the feet may become dry and scaly; the skin all over the foot may become red, and vesicular eruptions may appear.

Three groups of fungal pathogens, referred to as dermatophytes, have been shown to cause tinea pedis: Trichophyton sp, Epidermophyton sp, and Microsporum sp. The disease manifests as a pruritic, erythematous, scaly eruption on foot and depending on its location, three variants have been described: interdigital type, moccasin type, and vesiculobullous type.

Athlete’s foot Epidemiology Perspective
The Athlete’s foot epidemiology division provides the insights about historical and current patient pool and forecasted trend for the United States. The Athlete’s foot epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in the United States. The Athlete’s foot epidemiology is segmented by Diagnosed incident cases of Athlete’s foot and Incident cases of Athlete’s foot by subtype covering the United States from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Athlete’s foot Detailed Epidemiology Segmentation
The Athlete’s foot epidemiology covered in the report provides historical as well as forecasted epidemiology {Total Diagnosed Incident Cases and Subtype-specific Cases} scenario of Athlete’s foot in the United States from 2017 to 2030.
The Athlete’s foot report also provides the epidemiology trends observed in the United States during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report
• The Athlete’s foot report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The Athlete’s foot Epidemiology Report and Model provide an overview of the risk factors and global trends of Athlete’s foot in the United States
• The report provides insight about the historical and forecasted patient pool of Athlete’s foot in the United States
• The report helps to recognize the growth opportunities in the United States with respect to the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Athlete’s foot
• The report provides the segmentation of the Athlete’s foot epidemiology by Subtype-specific Cases of Athlete’s foot in the United States

Report Highlights
• 11-Year Forecast of Athlete’s foot epidemiology
• United States Coverage
• Total Incident Cases of Athlete’s foot
• Incident Cases according to segmentation: Subtype-specific Incidence
• Diagnosed cases of Athlete’s foot
KOL- Views
We interview, KOLs and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered
• What will be the growth opportunities in the United States with respect to the patient population pertaining to Athlete’s foot?
• What are the key findings pertaining to the Athlete’s foot epidemiology in the United States?
• What would be the total number of patients of Athlete’s foot in the United States during the forecast period (2017–2030)?
• At what CAGR the patient population is expected to grow in the United States during the forecast period (2017–2030)?
• What is the disease risk, burden and unmet needs of the Athlete’s foot?
• What are the current available treatments of Athlete’s foot?

Reasons to buy
The Athlete’s foot Epidemiology report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the global Athlete’s foot market
• Quantify patient populations in the global Athlete’s foot market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Athlete’s foot therapeutics in each of the markets covered
• Understand the magnitude of Athlete’s foot population by its severity
• The Athlete’s foot epidemiology report and model were written and developed by Masters and PhD level epidemiologists
• The Athlete’s foot Epidemiology Model developed is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk and Burden

• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered
• The United States
Study Period: 2017–2030
IQWiG (Institute for Quality and Efficiency in Health Care) suggests that Athlete’s foot is very common affecting 3 to 15% of the population. Similarly, a study published by Nigam et al. highlights that about 10% of the total population may be affected by dermatophyte infections of the toe clefts. It is mostly attributed to wearing of occlusive shoes for long periods.
The study by Muhannad Al Hasan et al. points towards an important fact that Tinea pedis is estimated to be the second most common skin disease in the United States, behind acne, and up to 15% of the population may manifest the disease.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Onychomycosis - Epidemiology Forecast to 2030

  • $ 2250
  • May 2020
  • 50 pages

‘Onychomycosis - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Onychomycosis epidemiology in the United States. Onychomycosis ...


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on